Molecule to market: Digital transformation trends in pharma

One of the greatest inefficiencies in life sciences and other process industries is the loss of knowledge between R&D, development and tech transfer into commercial manufacturing. Enhancing collaboration and connecting these stages through a continuous digital thread dramatically reduces risk, rework and time to market.

This panel from the 2026 Hannover Messe event brings together Gerry Keane, Group VP, Siemens Digital Industries Software, Maria Grahm, Head of Life Sciences, Siemens, and Niels Vandervoort, Director of Digital Transformation Synthetics, Johnson & Johnson Innovative Medicine, to explore how a continuous digital thread — from molecule to market — can break down the silos between discovery, development, tech transfer and commercial manufacturing.

Central to this discussion is Siemens' acquisition of Dotmatics, which adds scientific intelligence, including high-definition tools for scientists and the Luma AI command center, to Siemens' portfolio, giving the company an end-to-end offering for the life sciences industry that it did not have before.

What you'll learn:

• Why pharma R&D is at an inflection point - molecule complexity, compressed timelines, and rising competition are forcing a complete rethink of how drugs are discovered and developed
• The true cost of disconnected data - knowledge lost between R&D, tech transfer, and manufacturing creates rework, risk and delays worth tens of millions of dollars
• Why capturing data isn't enough - the real challenge is contextualized what was done and why, so that knowledge is institutionalized
• Why the time for digital transformation in life sciences is now - the platforms, models, and computational power needed to make the molecule-to-market digital thread a reality are finally here

Watch the video today to learn more.

Join us for a live webinar

Want to learn more about drug discovery and development? Join us for an upcoming live webinar on Wednesday, June 17 where our panel of experts will discuss how to accelerate drug development within a collaborative, data-driven environment. Register today to reserve your spot.

Get in touch with us

Have questions or want to learn more? Contact us today to connect with our team and discover how Siemens can help accelerate your journey from molecule to market.